Take a look at the Recent articles

Effect of flower and root of Aerva lanata (L.) on enzymes of carbohydrate metabolism in alloxan induced diabetic rats

Vidhya R

Post Graduate and Research Department of Biochemistry,Government Arts College (Autonomous), Kumbakonam - 612 001, Tamilnadu, India

Department of Biochemistry, Dharmapuram Gnanambigai Government Arts College for Women, Mayiladuthurai-609 001, Tamilnadu, India

Udayakumar R

Post Graduate and Research Department of Biochemistry,Government Arts College (Autonomous), Kumbakonam - 612 001, Tamilnadu, India

DOI: 10.15761/MCA.1000137

Article
Article Info
Author Info
Figures & Data

Abstract

Background: Diabetes mellitus is the most common endocrine disorders that impair glucose homeostasis resulting in hyperglycemia and glycosuria.

Methods: The present study was to evaluate the effect of flower and root of Aerva lanata (L.) on the activities of enzymes of carbohydrate metabolism in alloxan (150 mg/kg bw) induced diabetic rats. Oral administration of aqueous extracts of flower and root of A. lanata (200 mg/kg bw) to diabetic rats was done daily for 45 days.

Results: This study showed that decreased levels of hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen synthase and increased levels of lactate dehydrogenase and glycogen phosphorylase activities in liver of diabetic rats. The elevated levels of enzyme activities such as hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and lactate dehydrogenase were observed in kidney of diabetic rats.  The plant extracts treated diabetic rats showed that the above-mentioned enzymes activities were near normal as like as normal control rats. In liver and kidney, the gluconenogenic key enzymes like glucose-6-phosphatase and fructose-1, 6-bisphosphatase were increased in diabetic rats when compared to normal control rats. After oral administration of flower and root extracts of A. lanata treated to diabetic rats showed that decreased levels of above mentioned enymes activities. 

Conclusion: The results were compared and observed more or less similar with standard drug glibenclamide (1mg/ kg bw) treated rats.  So, the present study confirmed that the antidiabetic effect of flower and root of A. lanata on alloxan induced diabetic rats by maintaining the normal levels of carbohydrate metabolizing enzymes.

Key words

Aerva lanata, liver, kidney, metabolic enzymes

Introduction

Carbohydrates play a several crucial roles in the metabolic processes of living organisms. They serve as energy sources and as structural elements in living cells. The main role of carbohydrates is involved in the energy production process, because the glucose is a prominent energy source in almost all living cells and tissues and the major emphasis is placed on its synthesis, degradation, and storage. Living cells are in a state of ceaseless activity to maintain its life and each cell depends on highly coordinated several biochemical reactions. Carbohydrates are an important source of energy compound than protein. The energy-generating pathways of carbohydrate metabolism are glycolysis and tricarboxylic acid cycle. It is an ancient pathway found in almost all organisms, a small amount of energy is captured in the process of glucose molecule is converted to two molecules of pyruvate. Glycogen, a storage form of glucose in vertebrates is synthesized by glycogenesis when glucose levels are high and degraded by glycogenolysis when glucose is in short supply. Glucose can also be synthesized from non-carbohydrate precursors by reactions referred to as gluconeogenesis. The pentose phosphate pathway enables cells to convert glucose-6-phosphate, a derivative of glucose, to ribose- 5-phosphate (the sugar used to synthesize nucleotides and nucleic acids) and other types of monosaccharides. NADPH, an important cellular reducing agent, is also produced by pentose phosphate pathway [1].

Carbohydrate metabolism is focused on the synthesis and usage of glucose, a major fuel for most organisms. In vertebrates, glucose is transported throughout the body through blood. If cellular energy reserves are low, glucose is degraded by the glycolytic pathway. Glucose molecules not required for immediate energy production are stored as glycogen in liver and muscle. The energy requirements of many tissues (e.g., brain, red blood cells, and exercising skeletal muscle cells) depend on an uninterrupted flow of glucose. Depending on a cell’s metabolic requirements, glucose can also be used to synthesize, for example, other monosaccharides, fatty acids, and certain amino acids [1].  Insulin is an important hormone in carbohydrate metabolism. Due to insulin secretion is insufficient or impaired that leads to diabetes mellitus.

Diabetes mellitus is a group of heterogenous, hormonal and metabolic disorders characterized by hyperglycemia and glucosuria with disturbances of carbohydrates, fat and protein metabolism resulting from defects in insulin secretion and or insulin action [2]. Diabetes mellitus, a chronic disorder is associated with long-term complications, including retinopathy (eye), nephropathy (kidney) and angiopathy (heart). Diabetes mellitus is considered to be a major risk factor for cardiovascular disorders namely ischemic heart disease, cerebral stokes and peripheral artery disease leading to increased mortality of diabetes [3]. The prevalence of diabetes is increasing rapidly worldwide and the World Health Organization (2003) has predicted that by 2030 the number of adults with diabetes would have almost doubled worldwide, from 177 million in 2000 to 370 million. Experts project that the incidence of diabetes is set to soar by (64%) by 2025‚ meaning that a staggering 53.1 million citizens will be affected by the disease [4]. The estimated worldwide prevalence of diabetes among adults in 2010 was 285 million (6.4%) and this value is predicted to rise to around 439 million (7.7%) by 2030 [5].

Many drugs are available for the treatment of diabetes, but their long-term use may cause adverse side effects and hence, the increased search for natural remedies to effective treatment of diabetes exists [6]. Plants have always been a very good source of drugs and many of the presently available drugs are directly or indirectly made from them [7]. Plants used for medicinal purposes are frequently considered to be less toxic and induces fewer side effects than synthetic ones. Plants are most often implicated as having anti-diabetic effects contain glycosides, alkaloids, terpenoids, flavonoids and carotenoids [8]. Antihyperglycaemic effects of these plants are due to their capability to improve the function of pancreatic tissues by causing an increase in insulin output or inhibit the intestinal absorption of glucose or the facilitation of metabolites in insulin dependent processes [9].  More than 800 plant species have been reported to be possessing hypoglycemic activity in available literatures [10]. In recent times, focus on plant research has increased throughout the world and the immense potential of medicinal plants used in various traditional systems has been established scientifically. Screening of plants with ethno medical use is being lived to increase the odds in discovering new medicines [11].  In ancient times, medicinal plants and herbs were used as remedy for serious health complications. Medicinal plants and their bioactive constituents are used for the treatment of diabetes throughout the world. Many indigenous Indian medicinal plants have been found useful for managing diabetes [12,13].

Aerva lanata is an important medicinal plant of Amranthaceae and known as polpala. It is a prostrate to decumbent sometimes erect herb, found throughout tropical India as a common weed in field and wasteland. The plant is used for curing diabetes, anthelmintic, demulcent and it is helpful in lithiasis, cough, sore throat and wounds. The plant has been used as diuretic, antidiabetic, expectorant and hepatoprotective in traditional system of medicine [14]. The plant A. lanata possess antimicrobial and cytotoxicity [15], diuretic [16], urolithiasis [17] and anti-inflammatory [18], antibacterial [19] activities. It has been reported that Canthin-6-one and β-carboline alkaloids were isolated from leaves of A. lanata [20]. The alcoholic extract of shoots of A. lanata has shown significant antidiabetic activity. There is no detailed study on antidiabetic activity of flower and root of A. lanata. So, the present study was aimed to determine the effect of aqueous extracts of flower and root of A. lanata on carbohydrate metabolic enzymes activities in alloxan induced diabetic rats.

Materials and Methods

Collection and preparation of plant material: The medicinal plant Aerva lanata was collected from in and around Mayiladuthurai at Nagapattinum District, Tamilnadu, India. The plant was identified and authenticated by Dr. S. John Britto, Director, Rapinat Herbarium and Centre for Molecular Systematics, Department of Botany, St. Joseph’s College, Tiruchirappalli, Tamilnadu, India. The flower and root of A. lanata were separated and washed thoroughly in running tap water to remove soil particles and adhered debris and then finally washed with sterile distilled water. The flower and root of A. lanata were dried under shade and ground well into powder. The powdered materials were stored in air tight containers untill the time of use.

Preparation of aqueous extracts: 30 g powder of flower and root were soaked separately in distilled water for 12 to 16 hours and boiled and then it was filtered through muslin cloth and then Whatmann no. 1 filter paper. The aqueous extracts were concentrated and made the final volume to one-fifth of the original volume [21]. The paste form of extracts was stored in an air tight container at 4 ºC.

Experimental animals: Albino rats (Wistar) weight ranges between 150-200 g of both sexes were used for this study. They were housed in polypropylene cages under standard laboratory conditions (12-h light / 12-h dark cycle, 21 ± 2 ºC, and relative humidity 55 %). The animals were given standard rodent pellets and water ad libitum. The rats were acclimatized to laboratory condition for 7 days before commencement of experiment. Ethical clearance for handling animals for this study was obtained from Institutional Animal Ethical Committee (IAEC) of SASTRA University, Thanjavur, Tamilnadu India. The experiments were conducted as per the guidelines of CPCSEA, Chennai, India (Approval no: 211/ SASTRA /IAEC/RPP).

Induction of diabetes mellitus: Diabetes was induced by the single intraperitoneal injection of alloxan at the dose of 150 mg/kg b.w. The alloxan was dissolved in distilled water, and then used to induce diabetes mellitus. Fasting blood glucose of the animals was measured after 14 days of alloxan injection using glucometer.  Rats with fasting blood glucose above 200 mg/dl were considered as diabetic rats.

Drug administration: After 14 days of alloxan induction, the aqueous extract of flower and root of A. lanata were administered orally through intragastric tube at the dose of 200 mg kg-1 body weight.

Group I: Normal control – received only distilled water during the experimental period.

Group II: Diabetic control.

Group III: Diabetic rats were daily treated with A. lanata flower extract (200 mg /kg body weight) dissolved in distilled water by orally through intragastric tube for 45 days.

Group IV: Diabetic rats were daily treated with A. lanata root extract (200 mg/kg body weight) dissolved in distilled water by orally through intragastric tube for 45 days.

Group V: Diabetic rats were daily treated with standard drug glibenclamide (1 mg/kg body weight) dissolved in distilled water by orally through intragastric tube for 45 days.

Collection of blood sample and tissues: After the experimental period, the animals were kept fasted overnight and sacrificed by cervical decapitation under mild anesthesia. Blood was collected on decapitation and serum was separated by centrifugation at 2500 rpm for 15 min. The collected serum was used for the analysis of the activities of ALT, AST and γGT. Liver and kidney were dissected out immediately rinsed with ice cold saline and used for the further study like analysis of metabolic enzymes activities.

Biochemical studies

The collected samples like serum and tissues were subjected to biochemical analysis. Blood glucose was analysis by Folins Wu method [22], AST and ALT were estimated by the method of Reitman et al. [23], gamma glutamyl transpeptidase was assayed by the method of Szasz et al. [24] and hexokinase was assayed by the method of Brandstrup et al. [25]. Pyruvate kinase was estimated by the method of Pogson et al. [26] and lactate dehydrogenase was assayed by the method of King [27]. Glucose -6-phosphate dehydrogenase was measured the by the method of Gancedo and Gancedo [28], glucose -6-phosphatase was assayed by the method of Koide et al. [29], fructose-1-6-diphosphatase was estimated by the method of Gancedo and Gancedo [28], glycogen content was assayed by the method of Carroll et al. [30], glycogen synthetase and glycogen phosphorylase were assayed by the method of Leloir and Goldemberg [31] and Carnblath et al. [32] respectively.

Statistical analysis

The results of the present study were subjected to statistical analysis and all the results were expressed as means ± SE. The statistical significance was evaluated by one-way analysis of variance (ANOVA) using SPSS (statistical package for social sciences) Ver. 11 and the individual comparison were obtained by Duncan’s Multiple Range Test (DMRT). The values were considered statistically significant at 5% level (p≤0.05). Values with identical letter are not significantly different according to DMRT at 5% level.

Results

The level of blood glucose and the activities of enzymes like aspartate transaminase (AST), alanine transaminase (ALT) and gamma glutamyl transpeptidase (γGT) were analyzed in normal and experimental rats the results were represented in (Table 1). The increased levels of activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma glutamyl transpeptidase (γGT) were observed in serum of diabetic rats when compared with normal control rats. After administration of aqueous extracts of flower and root of A. lanata to diabetic rats showed significantly decreased levels of AST, ALT and γGT, which were more or less similar to standard drug glibenclamide (1mg/ kg bw) treated rats.

Table 1. Effect of   flower and root extracts of A. lanata on glucose, AST, ALT and γGT. (Values are expressed as means ± S.E. of six samples from each group,Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

      Groups

 

Blood sugar

AST

ALT

γGT

(mg/dl)

(IU/L)

(IU/L) 

 (IU/L)

Group I

Normal control

92.74±3.64a

29.81±1.17a

77.64±3.05b

18.43±0.72a

Group II

Diabetic control

286.72± 11.26d

59.47±2.33d

118.28±4.64d

30.66±1.20c

Group III

Diabetic + Flower extract  (200mg/kg bw)

143.34±5.63c

45.90±1.80c

102.22±4.01c

25.62±1.00b9

Group IV

Diabetic + Root extract 

(200mg/kg bw)

119.44±4.69b

37.01±1.45b

84.72±3.32b

20.49±0.80a

Group V

Diabetic + Glibenclamide 

(1mg/kg bw)

101.47±3.98a,b

32.69±1.28a,b

80.46±0.76a

19.4±0.76a

 The effect of flower and root extracts of A. lanata on hexokinase, pyruvate kinase, lactate dehydrogenase, glucose -6-phosphate dehydrogenase, glucose-6- phosphatase and fructose-1,6-bisphosphatase in alloxan induced diabetic rats was studied and the results were presented in (Table 2). The activities of hexokinase, pyruvate kinase and glucose-6-phophate dehydrogenase were decreased in liver of diabetic rats, but the activity of lactate dehydrogenase was significantly increased. After the plant extracts were administered to diabetic rats significantly increased levels of enzymes activities of hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase was observed. The administration of root extract of A. lanata showed predominant recovery than flower. In the present study, the glucose-6-phosphatase and fructose 1, 6- bisphosphatase activities were elevated in liver of alloxan induced diabetic rats. After 45 days, aqueous extracts of flower and root of A. lanata (200 mg/kg b.w.) treated diabetic rats showed that decreased levels of gluconeogenic key enzymes activities in liver. The root of A. lanata showed higher activity than flower extract.

Table 2. Effect of flower and root extracts of A. lanata on metabolic enzymes like hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-bisphosphatase in liver. (Values are expressed as means ± S.E. of six samples from each group, Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

Groups

Hexokinase

(μmoles of glucose -6-phosphate formed / hr/mg of protein)

Pyruvate kinase

(µmoles of pyruvate formed /min/mg of protein)

Lactate dehydrogenase

(μmoles of pyruvate formed/hr/mg of protein)

Glucose -6-phosphate dehydrogenase

(U/min/mg of protein)

 

Glucose-6-phosphatase

(μmoles of phosphate liberated/ hr/mg of protein)

Fructose-1,6-bis phosphatase

(μmoles of phosphate liberated/hr/mg of protein)

Group I

Normal  control

260.51±10.23c

10.65±0.41d

239±9.39a

2.39±0.09d

1034.52±40.65a

498.89±19.60a

Group II

Diabetic control

128.84±5.06a

4.65±0.18a

473.49±18.60c

0.96±0.03a

1921.79±75.52c

816.12±32.07c

Group III

Diabetic +  Flower extract   (200mg/kg bw)

204.11±8.02b

6.36±0.25b

306.12±12.02b

1.47±0.05b

1229.21±48.30b

715.14±28.10b

Group IV

Diabetic +  Root extract  (200mg/kg bw)

253.2±9.95c

8.81±0.34c

265.31±10.42a

2.25±0.09c,d

1048.56±41.20a

511.23±20.09a

 

  Group V

  Diabetic + Glibenclamide  (1mg/kg bw)

254.22±9.99c

9.39±0.36c

275.50±10.82a,b

2.14±0.08c

1123.33±44.14a,b

556.11±21.85a

The effect of flower and root extracts of  A. lanata on carbohydrate metabolic enzymes like hexokinase, pyruvate kinase, glucose-6 phosphate dehydrogenase, lactate dehydrogenase, glucose-6-phosphatase and fructose 1, 6- bisphosphatase in alloxan induced diabetic rats were studied and the results were given in (Table 3). The present study showed that the increased levels of hexokinase, pyruvate kinase, glucose-6 phosphate dehydrogenase, lactate dehydrogenase, glucose-6-phosphatase and fructose 1, 6- bisphosphatase activities in kidney of alloxan induced diabetic rats. After 45 days the administration of aqueous extracts of flower and root of A. lanata (200 mg/kg bw) to diabetic rats showed decreased levels of glycolytic enzymes such as hexokinase, pyruvate kinase and lactate dehydrogenase and decreased levels of enzymes of HMP shunt and key enzymes of gluconeogenic pathway in kidney. Among the both extracts, the root of A. lanata was showed higher activity than flower extract.

Table 3. Effect of flower and root extracts of A. lanata on metabolic enzymes like hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-bisphosphatase in kidney. (Values are expressed as means ± S.E. of six samples from each group,Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

               Groups

 

Hexokinase

(μmoles of glucose -6-phosphate formed / hr/mg of protein)

Pyruvate kinase

(μmoles of pyruvate formed/min/mg of protein

Lactate dehydrogenase

(μmoles of pyruvate formed/hr/mg of protein)

Glucose-6-phosphate dehydrogenase

(U/min/mg of protein)

Glucose-6-phosphatase

(μmoles of phosphate liberated/hr/mg of protein )

 

Fructose-1,6- bisphosphates

(μmoles of phosphate liberated/hr/mg of protein )

Group I

Normal  control

143.00±5.61a

9.2±0.36a

483.99±19.01a

1.10±0.04a

300±10.01a

510±20.07a

Group II

Diabetic control

290.19±11.4c

24.53±0.96d

715.83±28.13b

1.65±0.06c

590±20.06d

1980±70.58c

Group III

Diabetic + Flower extract (200mg/kg bw)

173.6±6.82b

15.3±0.6c

518.77±20.38a

1.32±0.05b

420±10.05c

990±30.04b

Group IV

Diabetic + Root extract  (200mg/kg bw)

157.59±6.19a,b

10.95±0.43a,b

509.18±20.00a

1.13±0.04a

350±10.18b

610±20.04a

Group V

Diabetic + Glibenclamide  (1mg/kg bw)

 

169.11±6.64b

11.77±0.42b

525.6±20.65a

1.08±0.04a

290±10.01a

490±10.04a

The effect of aqueous extracts of flower and root of A. lanata on the levels of liver glycogen and glycogen metabolic enzymes like glycogen synthase and glycogen phosphorylase were studied and the results were represented in (Table 4). Alloxan induced diabetic rats showed significantly reduced levels of glycogen content in liver tissue. After 45 days, the oral administration of flower and root extract of A. lanata significantly increased the level of glycogen content in liver, which was as like as standard drug glibenclamide treated rats. Alloxan induced diabetic rats showed significantly decreased levesl of glycogen synthesis and the key enzyme like glycogen synthase and simultaneously increased glycogen degradation and the main enzyme glycogen phosphorylase in liver, which is due to decreased insulin activity and increased glucagon level in liver cells. The administration of flower and root extracts of A. lanata to diabetic rats showed reverse action of these key enzymes of glycogen metabolism.

Table 4.  Effect of flower and root extracts of A. lanata on glycogen, glycogen synthase and glycogen phosphorylase in liver. (Values are expressed as means ± S.E. of six samples from each group, Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

      Groups

 

Liver glycogen

(mg of glucose/g of tissue)

Glycogen synthase 

 (μmoles of UDP formed /hr/ mg of protein)

Glycogen phosphorylase

(µmole  of  phosphate liberated/hr/mg of protein)

Group I 

Normal control

41.61±1.63c,d

865.17±33.99c

667.19±26.21b

Group II

Diabetic control

22.84±0.89a

575.49±22.61a

899.80±3.53a

Group III

Diabetic + Flower extract (200mg/kg bw)

27.72±1.08b

701.87±27.58b

807.95±31.75c

Group IV

Diabetic + Root extract  (200mg/kg bw)

40.65±1.59c

836.4±32.86c

735.63±28.9b,c

Group V

Diabetic + Glibenclamide  (1mg/kg bw)

45.69±1.79d

806.04±31.67c

749.12±29.43c

Discussion

Over production of blood glucose by means of excessive hepatic glycogenolysis and gluconeogenesis and decreased utilization of glucose by the tissues is one of the fundamental basic of hyperglycemia in diabetes mellitus [33]. The flower and root of A. lanata treated diabetic rats showed that decreased levels of blood glucose and it may be due to increased production of insulin in beta cells of pancreas and increased utilization of glucose by tissues. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are excellent markers for diagnostic purpose, which play a main role in the conversion of amino acid to keto acid. AST was found in many tissues like liver, kidney, heart, brain and skeletal muscle and it is not specific liver enzyme, but ALT is more specific liver enzyme found in large amount in liver when compared to other tissues. Moreover, ALT and AST are marker enzymes for liver function and integrity [34], which are liberated into the blood whenever liver cells are damaged and the serum enzyme activity is increased.  Similarly, in this study the increased levels of ALT and AST were observed in diabetic control. Hence it indicates that diabetes may induce hepatic dysfunction in rats and these elevations are also associated with cell necrosis of many tissues. The increase in the activities of ALT and AST in serum may be due to the leakage of the enzymes from liver cytosol to blood stream which gives an indication of the hepatotoxic of alloxan. The restoration of normal levels of these enzymes indicates normal functioning of liver under effective treatment [35]. The elevation of liver biomarker enzymes such as AST and ALT in alloxan induced diabetic rats that lead to leakage of enzymes, which indicates the liver damage [36]. Increased activities of transaminases which are active in the absence of insulin because of increased availability of amino acids in diabetes are due to increased break down of protein. The elevated transaminases activities were significantly reduced in aqueous extracts of flower and root of A. lanata treated diabetic rats. The diabetic complications such as increased gluconeogenesis and ketogenesis may be due to elevated levels of transaminase activity [37].

γGT catalyzes the transfer of γ-gutamyl group from γ-glutamyl peptides to another peptide or L-amino acids or water. The assay of γGT is a helpful adjunct in detecting hepatic damage. In this study, a significant elevation of the activity of γGT was observed in serum of alloxan induced diabetic rats and this is in accordance with earlier investigation [38]. The elevated activity of γGT in serum takes place as a result of hepatic induction of enzyme. In addition, hepatocelluar damage or cholestasis may also contribute to the elevated enzyme activity. A significantly increased level of γGT was also observed in untreated diabetic rats. γGT is found in hepatocytes and biliary epithelial cells and, can leak to blood in pancreatic disease, renal failure, and diabetes [39].  After 45 days, the oral administration of flower and root extracts of A.lanata to alloxan induced diabetic rats showed significantly decreased level of γGT activity.

Liver is the candidate organ involved in glucose homeostasis. It is the main site for glycolysis, a process where glucose is degraded and gluconeogenesis, where glucose is synthesized from lactate, amino acids and glycerol. The glycolysis and gluconeogenesis are important metabolic pathways that balance the glucose load in our body [40]. It plays an important role in the maintenance of blood glucose level by regulating its metabolism. Hexokinase, which brings about the first phosphorylation step of glucose metabolism, is reduced significantly in diabetic rats [41]. Insulin influences the intracellular utilization of glucose in a number of ways. Insulin increases hepatic glycolysis by increasing the activity and amount of several key enzymes including hexokinase and pyruvate kinase. Hexokinase is universally present in cells of all types. Hexokinase catalyses the conversion of glucose to glucose -6-phosphate and plays a control role in the maintenances of glucose homeostasis. In the liver, the hexokinase is an important regulator of glucose storage and disposal [42]. The activity of hexokinase was significantly reduced in the liver of diabetic rats resulting in the diminished utilization of glucose and it leads to increased amount of glucose [43]. The increased level of hexokinase activity was observed in aqueous extracts of flower and root of A. lanata treated diabetic rats and is suggested that the activation of glycolysis leading to great utilization of glucose in liver cell.

During diabetes, liver shows decrease in weight due to enhanced catabolic processes such as glycogenolysis, lipolysis and proteolysis, which is the outcome of lack of insulin and /or cellular glucose in liver cells [44]. This may be the reason for the diminished consumption of glucose in the system and increased blood glucose level. In alloxan induced diabetic rats, the insulin administration stimulated transcription of hexokinase mRNA synthesis and this enhanced the rate of synthesis and activity of the enzyme [45]. So, in this study the mechanism may be played by A. lanata extract in enhancing the hexokinase activity in diabetic treated rats.  

Pyruvate kinase is a key enzyme of the glycolytic pathway whose activity and mRNA levels in the liver fluctuate according to the dietary status. Enzyme activity and mRNA concentration n strongly decrease with fasting and strongly increase after refeeding a high carbohydrate diet [46]. In vivo studies have shown that the expression of the pyruvate kinase gene is regulated by hormones and carbohydrates at both transcriptional and post-transcriptional levels. The major negative effector is glucagon and its second messenger, cyclic AMP; the major positive effectors are carbohydrates in the presence of insulin, thyroid hormones, and glucocorticoids which appear to play a “permissive” role [47,48]. Noguchi et al. [49] reported the pyruvate kinase is regulated at mRNA levels in insulin dependent diabetes. The role of pyruvate kinase is catalyzes the conversion of phosphoenolpyruvate to pyruvate. The present study is also showed that the increased level of pyruvate kinase in diabetic rats treated with flower and root of A. lanata. Similar result was observed in mangiferin and glibenclamide treated diabetic rats where increased the activity of pyruvate kinase that may leads to increase the utilization of glucose [50]. The findings of this study suggested that the flower and root of A. lanata showed the improvement in the glucose metabolism by increase the utilization of glucose.The activity of glucose-6-phosphate dehydrogenase, the rate limiting enzyme of the pentose phosphate pathway oxidative reaction was depressed in the liver of postmitochondiral fraction in diabetic rats. Zhang et al. [51] observed that increased level of glucose caused inhibition of glucose-6-phosphate dehydrogenase. 

Lactate dehydrogenase in anaerobic glycolysis, catalyses the conversion of pyruvate to lactate which subsequently is converted to glucose in gluconeogenesis flux and the reaction occurs in both cytosolic and mitochondrial compartments. LDH activity is found to be altered by insulin, glucose, NADH, as well as increases in mitochondrial membrane potential, cytosolic free ATP and cytosolic free Ca2+ [52]. The decreased level of activity of LDH in tissues could be important to ensure that a high proportion of both pyruvate and NADH, supplied by glycolysis, is subsequently oxidized by mitochondria. This excessive pyruvate is converted to lactate for which LDH is needed and therefore the activity of LDH may be increased due to less insulin availability in diabetes [53,54].

In diabetic condition, an increased activity of lactate dehydrogenase was observed [55,56]. Lactate dehydrogenase and aldolase are the bifunctional enzymes involved in the glycolytic pathway [57]. The LDH system reflects the nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide (NAD+/ NADH) ratio indicated by lactate/pyruvate ratio of hepatocyte cytosol [58]. The activity of LDH was increased in diabetes due to glucose stimulated insulin secretion [59]. The A. lanata and glibenclamide treated diabetic rats were showed normal LDH activity and this may be regulation of NAD+/NADH ratio by glucose oxidation.

The kidney is involved in the regulation of glucose homeostasis and abnormalities were found in diabetes mellitus via three different mechanisms such as (i) release of glucose into the circulation via gluconeogenesis (ii) uptake of glucose from the circulation to satisfy its energy needs and (iii) reabsorption into the circulation of glucose from glomerular filtrate to conserve glucose carbon [60]. During diabetes, kidney shows increase in weight due to glucose–over utilization and subsequent enhancement in glycogen synthesis, lipogenesis and protein synthesis [44]. These changes may be leads to series of microvascular renal complications, which involves a series of metabolic changes in the pathogenesis of diabetic nephropathy. In kidney, an over utilization of cellular glucose occurs through elevated activities of glycolytic and NADP-linked lipogenic enzymes such as glucose-6-phosphate dehydrogenase, malic enzymes and isocitrate dehydrogenase (ICDH) [61,62].

Kidney is insulin independent tissue for the uptake of glucose and this primarily reflects the differences in their ability to metabolize cellular glucose. As described earlier, in the diabetic condition the theory of glucose over and under utilization by the peripheral tissues plays a central role in disorder of glucose metabolism leading to elevated systemic glucose. In kidney, overutilization of cellular glucose occurs through elevated activities of the glycolytic enzymes. However renal gluconeogenic enzymes are elevated, similar to hepatic gluconeogenic enzymes thereby correlated to the uncontrolled glucose homeostasis at both cellular and systemic level [63].

The kidney can be considered two separate organs because glucose utilization occurs predominantly in the renal medulla, whereas glucose release is confined to the renal cortex [64]. This functional partition is a result of differences in the distribution of various enzymes along the nephron. For example, cells in the renal medulla have appreciable glucose phosphorylating and glycolytic enzyme activity and like the brain, they are obligate user of glucose [65]. These cells however, lack glucose-6-phosphate dehydrogenase and other gluconeogenic enzymes. Thus, although they can take up, phosphorylation of glycolysis and accumulate glycogen, they cannot release free glucose into the circulation [64]. The cytotoxicity of xenobiotics can be evaluated using serum marker enzymes. One such enzyme is lactate dehydrogenase, which though distributed throughout the body, it possesses isoenzymes recognized as marker for liver muscle lesion. It is important to exclude the possibility that the diabetes itself damage the tissue in such a way that activities of lactate dehydrogenase are attached [66]. Elevated serum lactate dehydrogenase levels in diabetic rats indicate cardiac muscular damage [67]. The quantity of enzyme released from damaged tissue is a measure of the number of necrotic cells.

The activity of glucose-6-phosphate dehydrogenase was increased in kidney of diabetic rats, which might lead to renal hypertrophy [68]. The significant changes in glucose-6-phosphate dehydrogenase lead to effect on cell growth and cell death [69]. The activity of glucose-6-phosphate dehydrogenase was increased in diabetes that might result in modulating the functioning of HMP shunt and the production of reducing equivalents such as NADH and NADPH. In this study the flower and root extracts of A. lanata treated diabetic rats, glucose-6-phosphate dehydrogenase activity was significantly reduced to near normal.

For the assessment of antidiabetic potency of the plant extract measured the activity of hepatic and kidney fructose 1, 6 bisphosphatase and glucose -6-phosphatase are important regulatory enzymes in gluconeogenesis. The final step of glucose production is catalyzed by glucose-6-phosphatase in kidney and liver. So, the glucose-6-phosphatase has an important role in glucose homeostasis in kidney and liver [70].  During the diabetic condition, fructose 1, 6- bis phosphatase hydrolyzes the fructose 1, 6- bisphosphate into fructose -6-phosphate in the gluconeogenesis [71]. In diabetic animals, the glucose-6-phosphatase and fructose 1, 6-bisphosphatase levels were observed to increase in kidney [72]. The increased activities of glucose-6-phosphatase and fructose 1, 6 bisphosphatase in liver and kidney of the alloxan induced diabetic rats may be due to insulin deficiency. In type I and type II diabetes the excessive release of glucose into the circulation is a major factor responsible for fasting hyperglycemia. Increased renal gluconeogenic enzymes activity [73] and increased renal glucose release have been consistently demonstrated in studies of diabetic animals [74].

Administration of alloxan causes decrease in glycogen content due to enhanced glycogenolysis which is due to insulin deficiency. So, the normal capacity of the liver to synthesize glycogen is impaired [75]. Restoration in glycogen level with treatment may be explained by the recovery of insulin and insulin control the activity of glycogen synthetase [76]. Glycogen synthesis in the rat liver and skeletal muscle is impaired in diabetes [77]. Glycogen is primary intracellular storable form of glucose and its level in various tissues especially skeletal muscles are a direct reflection of insulin activity because insulin promotes intracellular glycogen deposition by stimulating glycogen synthase and inhibiting glycogen phosphorylase. Since alloxan causes selective destruction of β cells of islet of langerhans resulting in marked decrease in insulin level, it is rational that glycogen level in liver and muscles are decreased as they depend on insulin for influx of glucose [78].

Conclusion

The present study showed that the flower and root extracts of A. lanata regulate the carbohydrate metabolic enzymes activities in alloxan induced diabetic rats. The extracts of flower and root of A. lanata was significantly maintained the levels of carbohydrate metabolic enzymes such as aerobic and anaerobic glycolytic key enzymes, HMP shunt, gluconeogenic key enzymes and glycogen metabolic enzymes were restored to near normal levels in liver and kidney. The higher level of antidiabetic activity was observed in root extract of A. lanata treated diabetic rats than flower extract. These findings suggest that the A. lanata may be a potential source for the development of new oral hypoglycemic drugs.

Conflicts of Interest

The authors declare no conflict of interest in this study. 

References

  1. McKee T, McKee, Kristova JR (2011) Biochemistry. The Molecular Basis of Life, In: carbohydrate metabolism, 5 edn. Oxford University Press, USA, 1: 3.
  2. World health Organization (1999) Definition diagnosis and classification of diabetes mellitus and its complications. World Health Organization, Department of non-communicable disease surveillance, Geneva, Switzerland.
  3. Njolstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, et al. (2003) Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signalling pathway. Diabetes 52: 2854-2860. [Crossref]
  4. Rowley WR, Bezold C (2012) Creating public awareness: state 2025 diabetes forecasts. Popul Health Manag 15: 194-200. [Crossref]
  5. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14. [Crossref]
  6. Nabeel MA, Kathiresan K, Manivannan S (2010) Antidiabetic activity of the mangrove species Ceriops decandra in alloxan-induced diabetic rats. Journal of Diabetes 2: 97 -103.
  7. Patel DK, Prasad SK, Kumar R, Hemalatha S (2012) An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J Trop Biomed 2: 320-330.
  8. Loew D, Kaszkin M (2002) Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 16: 705-711. [Crossref]
  9. Ngondi JL, Emile JD, Zephyrin F, Julius O (2006) Hypoglycaemic effect of the methanol extract of Irvingia gabonensis seeds on streptozotocin diabetic rats. Afr J Tradit Complement. Altern Med 3: 74 - 77.
  10. Patel D, Prasad S, Kumar R, Hemalatha S (2012) An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J Trop Biomed 2: 320-330.
  11. Umar A, Ahmed QU, Muhammad BY, Dogarai BB, Soad SZ (2010) Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J Ethnopharmacol 131: 140-145. [Crossref]
  12. Thirumalai T, Beverly CD, Sathiyaraj K, Senthilkumar B, David E, et al. (2012) Ethnobotanical study of anti-diabetic medicinal plants used by the local people in Javadhu hills Tamilnadu, India. Asian Pac. J Trop Biomed 2: 910-913.
  13. Arumugam G, Manjula P, Paari N (2013) A review: anti diabetic medicinal plants used for diabetes mellitus. J Acute Dis 2: 196- 200.
  14. Kiritikar KR, Basu BD (1996) Indian Medicinal Plants. pp. 2064-2065
  15. Chowdhury D, Sayeed A, Islam A, Shah Alam Bhuiyan M, Astaq Mohal Khan GR (2002) Antimicrobial activity and cytotoxicity of Aerva lanata. Fitoterapia 73: 92-94. [Crossref]
  16. Udupihille M, Jiffry MTM (1986) Diuretic effect of Aerva lanata with water, normal saline and coriander as controls. Indian. J Physiol Pharmacol 30: 91-97.
  17. Rao SG (1985) Evaluation of an experimental model for studying urolithiasis effect of Aerva lanata on urinary stones. Indian Drugs 22: 640-643.
  18. Vetrichelvan T, Jegadeesan M, Senthil Palaniappan M, Murali NP, et al. (2000) Diuretic and antiinflammatory activities of Aerva Ianata in rats. Indian J Pharm Sci 62: 300–302.
  19. Vidhya R, Udayakumar R (2015) Antibacterial Potential of Different Parts of Aerva lanata (L.) Against Some Selected Clinical Isolates from Urinary Tract Infections. Br Microbiol Res J 7: 35-47.
  20. Zapesochnaya G, Kurkin V, Okhanov V, Miroshnikov A (1992) Canthin-6-one and beta-Carboline Alkaloids from Aerva lanata. Planta Med 58: 192-196. [Crossref]
  21. Parekh J, Nair R, Chanda S (2005) Preliminary screening of some folkloric plants from western India for potential antimicrobial activity. Indian J Pharmacol 37: 408-09.
  22. Folin 0, Wu H (1919) A system of blood analysis. J Biol Chem 38: 81.
  23. Reitman S, Frankel S (1957) A colorimetric method for the Determination of serum glutamate oxaloacetate and glutamate pyruvate transaminase. J Clin Path 28: 56- 61.
  24. Szasz G, Gruber W, Bernt E (1976) Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 22: 650-656. [Crossref]
  25. BRANDSTRUP N, KIRK JE, BRUNI C (1957) The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 12: 166-171. [Crossref]
  26. Pogson CI, Denton RM (1967) Effect of alloxan diabetes, starvation and refeeding on glycolytic kinase activities in rat epididymal adipose tissue. Nature 216: 156-157.
  27. KING J (1959) A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Technol 16: 265-272. [Crossref]
  28. Gancedo JM, Gancedo C (1971) Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Mikrobiol 76: 132-138. [Crossref]
  29. KOIDE H, ODA T (1959) Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin Chim Acta 4: 554-561. [Crossref]
  30. CARROLL NV, LONGLEY RW, ROE JH (1956) The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 220: 583-593. [Crossref]
  31. Leloir LF, Goldemberg SH (1962) Glycogen synthetase from rat liver: (Glucose) n + (UDPG)? (Glucose) n + 1 + UDP In: Colowick SP, Kalpan NO (Eds.), Methods in Enzymology. Academic Press, New York, pp: 145-147.
  32. Carnblath M, Randle PJ, Parmeggiani A, Morgan HE (1963) Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactase production, glycogen content and phosphorylase activity in the perused isolated rat heart. J Biol Chem 238: 1592-1597.
  33. Devi R, Singh V, Kumar AC (2010) Antidiabetic activity of Pilocarpus microphyllus extract on streptozotocin-induced diabetic mice. Int J Pharm Sci Rev Res 5: 87-92.
  34. Edwards CRW, Bouchier IAD, Haslet C, Chilvers ER (1995) Davidson’s Principles and Practice of Medicine, 17th ed. Churchill Livingstone, pp. 488-490.
  35. McAnuff M, Omoruyi F, Morrison E, Asemota H (2003) Hepatic function enzymes and lipid peroxidation in streptozotocin-induced diabetic rats fed bitter yam (Dioscorea polygonoides) steroidal sapogenin extract. Diabetologia Croatica 2: 17-23.
  36. Rathod NR, Raghuveer I, Chitme HR, Chandra R (2009) Free radical scavenging activity of Calotropis gigantea on streptozotocin-induced diabetic rats. Indian J Pharm Sci 71: 615-621.
  37. Ghosh S, Suryawanshi SA (2001) Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. Indian J Exp Biol 39: 748-759. [Crossref].
  38. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, et al. (1991) Changes in hepatic glutathione metabolism in diabetes. Diabetes 40: 344-348. [Crossref]
  39. Limdi JK, Hyde GM (2003) Evaluation of abnormal liver function tests. Postgrad Med J 79: 307-312. [Crossref]
  40. Prakasam S, Sethupathy S, Pugalendi KV (2002) Antihyperglycaemic effect of Caseariae sculenta root extracts in streptozotocin-induced diabetic rats. Pharmazie 57: 758-760.
  41. Nehal M, Baquer NZ (1989) Effects of diabetes and insulin-induced hypoglycemia on hexokinase and glucose-6-phosphate dehydrogenase in red blood cells. Biochem Int 19: 185- 191.
  42. O‘Doherty RM, Lehman DL, Telemaque-Potts S, Newgard CB (1999) Metabolic impact of glucokinase over expression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48: 2022-2027.
  43. Vestergaard H (1999) Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Dan Med Bull 46: 13-34. [Crossref]
  44. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, et al. (1998) Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102: 619-624. [Crossref]
  45. Spence JT (1983) Levels of translatable mRNA coding for rat liver glucokinase. J Biol Chem 258: 9143-9146. [Crossref]
  46. Weber A, Marie J, Cottreau D, Simon MP, Besmond C, et al. (1984) Dietary control of aldolase B and L-type pyruvate kinase mRNAs in rat. Study of translational activity and hybridization with cloned cDNA probes. J Biol Chem 259: 1798- 1802.
  47. Vaulont S, Munnich A, Decaux JF, Kahn A (1986) Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver. J Biol Chem 261: 7621-7625. [Crossref]
  48. Vaulont S, Munnich A, Marie J, Reach G, Pichard AL, et al. (1984) Cyclic AMP as a transcriptional inhibitor of upper eukaryotic gene transcription. Biochem Biophys Res Commun 125: 135-141. [Crossref]
  49. Noguchi T, Inoue H, Tanaka T (1985) Transcriptional and post-transcriptional regulation of L-type pyruvate kinase in diabetic rat liver by insulin and dietary fructose. J Biol Chem 260: 14393-14397. [Crossref]
  50. Periyar Selvam S, Balu PM, Sathiya moorthi P, Murugesan K (2009) Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 55: 206-214.
  51. Zhang Z, Yu J, Stanton RC (2000) A method for determination of pyridine nucleotides using a single extract. Anal Biochem 285: 163-167. [Crossref]
  52. Ainscow EK, Zhao C, Rutter GA (2000) Acute over expression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 49: 1149-1155.
  53. Awaji Y, Hashimoto H, Matsui Y, Kawaguchi K, Okumura K, et al. (1990) Isoenzyme profiles of creatine kinase, lactate dehydrogenase, and aspartate aminotransferase in the diabetic heart: comparison with hereditary and catecholamine cardiomyopathies. Cardiovasc Res 24: 547-554. [Crossref]
  54. Jones RG, Grant PJ, Brown D, Stickland M, Wiles PG (1988) A rise in the plasma activities of hepatic enzymes is not a common consequence of hypoglycaemia. Diabet Med 5: 253-255. [Crossref]
  55. Pozzilli A, Signore A, Leslie RDG (1997) Infection, Immunity and Diabetes. In International Text Book of Diabetes Mellitus, 2nd edn, PP: 1231-241.
  56. Lemieux G, Aranda M R, Fournel P, Lemieux C (1984) Renal enzymes during experimental diabetes mellitus in the rat. Role of insulin, carbohydrate metabolism and ketoacidosis. Can. J Physiol Pharmacol 62: 70-75.
  57. Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M (2009) Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 55: 206-214.
  58. Williamson DH, Lund P, Krebs HA (1967) The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103: 514-527. [Crossref]
  59. Fridlyand LE, Philipson LH (2010) Glucose sensing in the pancreatic beta cell: a computational systems analysis. Theor Biol Med Model 7: 15. [Crossref]
  60. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, et al. (1980) Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 303: 1313–1318.
  61. Sochor M, Baquer NZ, Ball MR, McLean P (1987) Regulation of enzymes of glucose metabolism and lipogenesis in diabetic rat liver by thyroid hormones. Biochem Int 15: 619-627. [Crossref]
  62. Raju J, Gupta D, Rao AR, Yadava K, Baquer NZ, et al. (2001) Trigonella foenum-graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes; Mol Cell Biochem 224: 45-51.
  63. Najma Zaheer B, Dhananjay G, Jayadev R (1998) Regulation of metabolic pathways in liver and kidney during experimental diabetes: effects of antidiabetic compounds. Indian J Clin Biochem 13: 63-80.
  64. Schoolwerth AC, Smith BC, Culpepper RM (1988) Renal gluconeogenesis. Miner Electrolyte Metab 14: 347-361. [Crossref]
  65. Cahill GF Jr (1970) Starvation in man. N Engl J Med 282: 668-675. [crossref]
  66. Ingram LR (2003) Liver functions. In: Anderson SC, Cockayne S. editor. In Clinical chemistry: concepts and applications. New York: McGraw-Hill; pp: 285-321.
  67. Hagar HH (2002) Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. Pharmacol Research 46: 213–219.
  68. Pessoa BS, Peixoto EB, Papadimitriou A, Lopes de Faria JM, Lopes de Faria JB, et al. (2012) Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin Angiotensin Aldosterone Syst 13: 56-66.
  69. Zhaoyun Z, Chong WL, Diane E, Handy YZ, Jane A, et al. (2010) High glucose inhibits glucose-6- phosphate dehydrogenase, leading to increased oxidative stress and ß-cell apoptosis. FASEB J 24: 1497-1505.
  70. Mitrakou A (2011) Kidney: its impact on glucose homeostasis and hormonal regulation. Diabetes Res Clin Pract 93 Suppl 1: S66-72. [Crossref]
  71. Du J, Say RF, Lü W, Fuchs G, Einsle O (2011) Active-site remodelling in the bifunctional fructose-1,6-bisphosphate aldolase/phosphatase. Nature 478: 534-537. [Crossref]
  72. Arati G, Sachdanandam P (2003) Therupeutic effect of Semecarpus and Cardium Linn, nut milk extract on carbohydrate metabolizing and mitochondrial TCA cycle and respiratory chain enzymes in mammary carcinoma rats. J Phar Pharmacol 55: 1283- 1290.
  73. Mithieux G, Vidal H, Zitoun C, Bruni N, Daniele N, et al. (1996) Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45: 891-896. [Crossref]
  74. WaldhÃousl W, Bratusch-Marrain P, Gasi AS, Korn A, Nowotny P, et al. (1982) Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23: 6-15. [Crossref]
  75. Dheer R, Bhatnagar P (2010) A study of the antidiabetic activity of Barleria prionitisLinn. Indian J Pharmacol 42: 70-73. [Crossref]
  76. Sridevi M, Subramanian S (2007) Hypoglycemic effect of Solanum surattense leaf-extract in streptozotocin induced diabetic rat. J Pharmacol Toxicol 6: 621-629.
  77. Huang X, Vaag A, Hanson M, Weng J, Goop L, et al. (2000) Impaired insulin stimulated expression of the glycogen synthase gene in skeletalmuscle of type 2 diabetic parents is acquired rather than inherited. J Clin Endocrinol Metab 85: 1584-1590.
  78. Bishop JS (1970) Inability of insulin to activate liver glycogen transferase D phosphatase in the diabetic pancreatomized dog. Biochimica Biophysica Acta 208: 208-218.

Editorial Information

Editor-in-Chief

Article Type

Research Article

Publication history

Received date: September 03, 2018
Accepted date: September 14, 2018
Published date: September 17, 2018

Copyright

© 2018 Vidhya R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Vidhya R (2018) Effect of flower and root of Aerva lanata (L.) on enzymes of carbohydrate metabolism in alloxan induced diabetic rats. Med Clin Arch 2: DOI: 10.15761/MCA.1000137

Corresponding author

Udayakumar R

Post Graduate and Research, Department of Biochemistry, Government Arts College (Autonomous), Kumbakonam - 612001, Tamilnadu India

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Table 1. Effect of   flower and root extracts of A. lanata on glucose, AST, ALT and γGT. (Values are expressed as means ± S.E. of six samples from each group,Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

      Groups

 

Blood sugar

AST

ALT

γGT

(mg/dl)

(IU/L)

(IU/L) 

 (IU/L)

Group I

Normal control

92.74±3.64a

29.81±1.17a

77.64±3.05b

18.43±0.72a

Group II

Diabetic control

286.72± 11.26d

59.47±2.33d

118.28±4.64d

30.66±1.20c

Group III

Diabetic + Flower extract  (200mg/kg bw)

143.34±5.63c

45.90±1.80c

102.22±4.01c

25.62±1.00b9

Group IV

Diabetic + Root extract 

(200mg/kg bw)

119.44±4.69b

37.01±1.45b

84.72±3.32b

20.49±0.80a

Group V

Diabetic + Glibenclamide 

(1mg/kg bw)

101.47±3.98a,b

32.69±1.28a,b

80.46±0.76a

19.4±0.76a

Table 2. Effect of flower and root extracts of A. lanata on metabolic enzymes like hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-bisphosphatase in liver. (Values are expressed as means ± S.E. of six samples from each group, Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

Groups

Hexokinase

(μmoles of glucose -6-phosphate formed / hr/mg of protein)

Pyruvate kinase

(µmoles of pyruvate formed /min/mg of protein)

Lactate dehydrogenase

(μmoles of pyruvate formed/hr/mg of protein)

Glucose -6-phosphate dehydrogenase

(U/min/mg of protein)

 

Glucose-6-phosphatase

(μmoles of phosphate liberated/ hr/mg of protein)

Fructose-1,6-bis phosphatase

(μmoles of phosphate liberated/hr/mg of protein)

Group I

Normal  control

260.51±10.23c

10.65±0.41d

239±9.39a

2.39±0.09d

1034.52±40.65a

498.89±19.60a

Group II

Diabetic control

128.84±5.06a

4.65±0.18a

473.49±18.60c

0.96±0.03a

1921.79±75.52c

816.12±32.07c

Group III

Diabetic +  Flower extract   (200mg/kg bw)

204.11±8.02b

6.36±0.25b

306.12±12.02b

1.47±0.05b

1229.21±48.30b

715.14±28.10b

Group IV

Diabetic +  Root extract  (200mg/kg bw)

253.2±9.95c

8.81±0.34c

265.31±10.42a

2.25±0.09c,d

1048.56±41.20a

511.23±20.09a

 

  Group V

  Diabetic + Glibenclamide  (1mg/kg bw)

254.22±9.99c

9.39±0.36c

275.50±10.82a,b

2.14±0.08c

1123.33±44.14a,b

556.11±21.85a

 

Table 3. Effect of flower and root extracts of A. lanata on metabolic enzymes like hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-bisphosphatase in kidney. (Values are expressed as means ± S.E. of six samples from each group,Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

               Groups

 

Hexokinase

(μmoles of glucose -6-phosphate formed / hr/mg of protein)

Pyruvate kinase

(μmoles of pyruvate formed/min/mg of protein

Lactate dehydrogenase

(μmoles of pyruvate formed/hr/mg of protein)

Glucose-6-phosphate dehydrogenase

(U/min/mg of protein)

Glucose-6-phosphatase

(μmoles of phosphate liberated/hr/mg of protein )

 

Fructose-1,6- bisphosphates

(μmoles of phosphate liberated/hr/mg of protein )

Group I

Normal  control

143.00±5.61a

9.2±0.36a

483.99±19.01a

1.10±0.04a

300±10.01a

510±20.07a

Group II

Diabetic control

290.19±11.4c

24.53±0.96d

715.83±28.13b

1.65±0.06c

590±20.06d

1980±70.58c

Group III

Diabetic + Flower extract (200mg/kg bw)

173.6±6.82b

15.3±0.6c

518.77±20.38a

1.32±0.05b

420±10.05c

990±30.04b

Group IV

Diabetic + Root extract  (200mg/kg bw)

157.59±6.19a,b

10.95±0.43a,b

509.18±20.00a

1.13±0.04a

350±10.18b

610±20.04a

Group V

Diabetic + Glibenclamide  (1mg/kg bw)

 

169.11±6.64b

11.77±0.42b

525.6±20.65a

1.08±0.04a

290±10.01a

490±10.04a

Table 4.  Effect of flower and root extracts of A. lanata on glycogen, glycogen synthase and glycogen phosphorylase in liver. (Values are expressed as means ± S.E. of six samples from each group, Values are not sharing a common superscript differ significantly at 5% level (p≤ 0.05) using Duncan’s Multiple Range Test (DMRT)).

      Groups

 

Liver glycogen

(mg of glucose/g of tissue)

Glycogen synthase 

 (μmoles of UDP formed /hr/ mg of protein)

Glycogen phosphorylase

(µmole  of  phosphate liberated/hr/mg of protein)

Group I 

Normal control

41.61±1.63c,d

865.17±33.99c

667.19±26.21b

Group II

Diabetic control

22.84±0.89a

575.49±22.61a

899.80±3.53a

Group III

Diabetic + Flower extract (200mg/kg bw)

27.72±1.08b

701.87±27.58b

807.95±31.75c

Group IV

Diabetic + Root extract  (200mg/kg bw)

40.65±1.59c

836.4±32.86c

735.63±28.9b,c

Group V

Diabetic + Glibenclamide  (1mg/kg bw)

45.69±1.79d

806.04±31.67c

749.12±29.43c